SELLAS Life Sciences Group Inc

NASDAQ:SLS   3:59:40 PM EDT
3.70
-0.02 (-0.54%)
Earnings Announcements

SELLAS Life Sciences Reports Q3 2020 Financial Results

Published: 11/13/2020 22:37 GMT
Sellas Life Sciences Group Inc (SLS) - Sellas Life Sciences Provides Business Update and Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.53.
As of September 30, 2020, Cash and Cash Equivalents Totaled Approximately $8.2 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.